WW INTERNATIONAL, INC.

Nasdaq · Services-Personal Services · Inc. VA · CIK 0000105319

$10.15 +2.22% $99.3M

High Impact Filing (7/10)

Vol

Market Cap$99.3M

Cap SizeMicro Cap

Inst. Holders7 funds

Inst. Value$12.7M

Inst. Activity2 buys / 2 sells

Reddit Sentiment57° Neutral

SEC Reports7

Press Releases2

Exchange Nasdaq·Sector Services-Personal Services·Inc. VA·CIK 0000105319·Prev Close $9.93

Recent Activity

May 15, 2026 SEC

WW International filed a DEFA14A (additional definitive proxy soliciting materials) on May 15, 2026, which is a manageme

DEFA14A — Impact 3/10

May 7, 2026 earnings_calendar

WW Q1 2026 Earnings Scheduled — 2026-05-07

Apr 27, 2026 SEC

WW International announced plans to utilize up to $40 million in cash to prepay and reduce its outstanding term loan, co

8-K — Impact 4/10

Apr 23, 2026 SEC

WW International announced it will release Q1 2026 earnings on May 7, 2026, ahead of market open, with a conference call

PRESS-RELEASE — Impact 3/10

Apr 15, 2026 Insider

Cotter Debra sold 1,200 shares

Chief Legal Off. & Secretary @ $0.00 ($0.00)

Apr 15, 2026 Insider

Cotter Debra sold 2,666 shares

Chief Legal Off. & Secretary @ $0.00 ($0.00)

Inst.

Fund 1 Investments, LLC — NEW

16,600 shares ($485.0K)

Inst.

TWO SIGMA INVESTMENTS, LP — ADD

15,697 shares ($458.6K)

Price Targets

Historical data — last covering-analyst action Jan 2026. No current recommendation available.

$28.33 (Jan 2026)

Current $10.15 Low $20.00 Median $30.00 High $35.00 3 analysts

$20.00 $35.00

Analyst Ratings

Historical distribution73% buy · 11 analysts · last covering-analyst action Jan 2026

3Strong Buy

5Buy

3Hold

0Sell

0Strong Sell

Historical Analyst Actions

Date	Firm	Action	Rating
Jan 15, 2026	Morgan Stanley	MAINTAIN	Equal-Weight → Equal-Weight

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$0.89 ▼ -29.3%	$0.11 — $2.19	29% YoY	3
Next Q	$1.04 ▼ -5.0%	$0.13 — $2.16	122% YoY	3
Current FY	$-2.84 ▼ -174.0%	$-5.63 — $1.79	-1643% YoY	3
Next FY	$-0.13 ▲ +77.0%	$-3.36 — $3.86	95% YoY	3

Latest Reports

NEUTRAL DEFA14A 3/10

WW International filed a DEFA14A (additional definitive proxy soliciting materials) on May 15, 2026, which is a manageme

May 15, 2026

NEUTRAL 8-K 4/10

WW International announced plans to utilize up to $40 million in cash to prepay and reduce its outstanding term loan, co

Apr 27, 2026

NEUTRAL Press 4/10

WW International announced an expanded collaboration with Novo Nordisk to offer eligible Med+ members discounted subscri

Mar 31, 2026

Top Institutional Holders

Fund	Value	Move
VANGUARD GROUP INC	$4.7M	NEW
BANK OF AMERICA CORP	$4.6M	NEW
MORGAN STANLEY	$2.4M	NEW
Fund 1 Investments, LLC	$485.0K	NEW
TWO SIGMA INVESTMENTS, LP	$458.6K	ADD

Recent Insider Trades

Date	Insider	Type	Value
Apr 15, 2026	Cotter Debra	A	$0.00
Apr 15, 2026	Cotter Debra	A	$0.00

Reddit Sentiment

57°

Neutral

Bearish Neutral Bullish

3 mentions 1 bullish 0 bearish

7 institutional holders with $12.7M total value (434,089 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, MORGAN.

Top Institutional Holders — 2025-Q4

#	Fund	Shares	Value	% of Tracked	Last Move
1	VANGUARD GROUP INC	161,011	$4.7M	37.1%	NEW
2	BANK OF AMERICA CORP /DE/	156,490	$4.6M	36.1%	NEW
3	MORGAN STANLEY	82,089	$2.4M	18.9%	NEW
4	Fund 1 Investments, LLC	16,600	$485.0K	3.8%	NEW
5	TWO SIGMA INVESTMENTS, LP	15,697	$458.6K	3.6%	ADD +43.9%
6	FMR LLC	2,127	$62.1K	0.5%	NEW
7	WELLS FARGO & COMPANY/MN	75	$2.2K	0.0%	TRIM -72.1%

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
Fund 1 Investments, LLC	NEW	—	16,600	—	$485.0K	2025-Q4
TWO SIGMA INVESTMENTS, LP	ADD	10,910	15,697	+43.9%	$458.6K	2025-Q4
WELLS FARGO & COMPANY/MN	TRIM	269	75	-72.1%	$2.2K	2025-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	EXIT	7,894	0	-100.0%	$0.00	2025-Q4
VANGUARD GROUP INC	NEW	—	158,317	—	$4.3M	2025-Q3
BANK OF AMERICA CORP /DE/	NEW	—	153,825	—	$4.2M	2025-Q3
MORGAN STANLEY	NEW	—	100,588	—	$2.8M	2025-Q3
UBS Group AG	NEW	—	43,038	—	$1.2M	2025-Q3
TWO SIGMA INVESTMENTS, LP	NEW	—	10,910	—	$298.5K	2025-Q3
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	NEW	—	7,894	—	$216.0K	2025-Q3
FMR LLC	NEW	—	2,127	—	$58.2K	2025-Q3

1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

Date	Insider	Title	Type	Shares	Price	Value
Apr 15, 2026	Cotter Debra	Chief Legal Off. & Secretary	A	1,200	$0.00	$0.00
Apr 15, 2026	Cotter Debra	Chief Legal Off. & Secretary	A	2,666	$0.00	$0.00

7 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 6 neutral. Avg impact: 3.7/10.

NEUTRAL DEFA14A 3/10

WW International filed a DEFA14A (additional definitive proxy soliciting materials) on May 15, 2026,

May 15, 2026

NEUTRAL 8-K 4/10

WW International announced plans to utilize up to $40 million in cash to prepay and reduce its outst

Apr 27, 2026

NEUTRAL PRESS-RELEASE 3/10

WW International announced it will release Q1 2026 earnings on May 7, 2026, ahead of market open, wi

Apr 23, 2026

NEUTRAL 8-K 3/10

WW International appointed healthcare executive Heather Thiltgen to its Board of Directors, effectiv

Apr 20, 2026

NEUTRAL 8-K 3/10

WW International announced the resignation of board member Michael Mason and new compensation arrang

Apr 17, 2026

NEUTRAL 8-K 3/10

WW International appointed Lisa Gavales and Sue Gove as independent directors, expanding the board t

Apr 7, 2026

BEARISH 8-K 7/10

WW International announced the resignation of CEO Tara Comonte and CFO Jaqueline Cooke, effective Ma

Apr 3, 2026

NEUTRAL 4/10

WW International announced an expanded collaboration with Novo Nordisk to offer eligible Med+ member

Mar 31, 2026

MIXED 6/10

WW International reported Q4 2025 results with total revenue of $162.8 million, down 12% year-over-y

Mar 16, 2026

Historical analyst distribution (last covering-analyst action Jan 2026): 73% buy across 11 analysts — 3 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jan 2026. No current recommendation available.

$28.33 mean target (Jan 2026)

$20.00 Low $35.00 High

Metric	Value
Current Price	$10.15
Target Low	$20.00
Target Mean	$28.33
Target Median	$30.00
Target High	$35.00
# Analysts	3
Recommendation	— (no recent coverage)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$0.89	$0.11	$2.19	29.2%	-29.3%	0↑ 1↓	$0.2B	-15.9%	3
Next Q 2026-09-30	$1.04	$0.13	$2.16	121.7%	-5.0%	0↑ 1↓	$0.2B	-10.8%	3
Current FY 2026-12-31	$-2.84	$-5.63	$1.79	-1643.5%	-174.0%	—	$0.6B	-11.0%	3
Next FY 2027-12-31	$-0.13	$-3.36	$3.86	95.3%	+77.0%	1↑ 0↓	$0.6B	1.9%	3

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$0.887
7d ago	$1.255	-0.368
30d ago	$1.255	-0.368
60d ago	$1.870	-0.983
90d ago	$1.870	-0.983

1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Jan 15, 2026	Morgan Stanley	MAINTAIN	Equal-Weight	Equal-Weight

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Buy %
May 1, 2026	3	5	3	73%
Apr 1, 2026	3	5	3	73%
Mar 1, 2026	3	5	2	80%
Feb 1, 2026	3	5	2	80%
Jan 1, 2026	3	5	2	80%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

57°

Neutral

Bearish Neutral Bullish

3 mentions 1 bullish 0 bearish 3 time periods

Reddit Sentiment History

Date	Mentions	Sentiment	Bullish	Threads
May 10, 2026	1	50° Neutral	0	1
May 10, 2026	1	50° Neutral	0	1
Mar 1, 2026	1	60° Warm	1	1

Recent Reddit Threads

r/pennystocks Bullish 2mo ago

$ANNA EU domestic natural gas

▲ 1 💬 1 ⚡ 0.5

r/wallstreetbets Neutral 11d 9h ago

$200,000.-- WW YOLO

▲ 1 💬 0 ⚡ 0.5

r/investing Neutral 9d 19h ago

Lets Talk About Margin...

▲ 0 💬 27

May 7, 2026

earnings_calendar

WW Q1 2026 Earnings Scheduled — 2026-05-07

May 1, 2026

other

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes <pre>

Apr 30, 2026

earnings_calendar

WW Q1 2026 Earnings Scheduled — 2026-04-30

Apr 27, 2026

other

Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global le

Apr 23, 2026

earnings

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results fo

Apr 20, 2026

other

Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global le

Apr 7, 2026

other

Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation <pre>New, Independent Directors B

Apr 3, 2026

other

Weight Watchers Announces Leadership Transition and Board Updates

Office of the CEO Established to Oversee Business Operations

Mar 31, 2026

contract

Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to

Mar 16, 2026

earnings

Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance

Mar 16, 2026

earnings_calendar

WW Q4 2025 Earnings After Market Close — 2026-03-16

Mar 3, 2026

earnings_calendar

WW Q4 2025 Earnings After Market Close — 2026-03-03